Skip to content

   Pharma Publications

Neuropsychopharmacology
  • Ketamine induced synaptic plasticity operates independently of long-term potentiation
    Published on 2024-06-19
    2 years ago
  • NIMH perspectives on future directions in neuroimaging for mental health
    Published on 2024-06-19
    2 years ago
  • Validation of a non-food or water motivated effort-based foraging task as a measure of motivational state in male mice
    Published on 2024-06-19
    2 years ago
  • In Memoriam: Larry J. Young, PhD
    Published on 2024-06-15
    2 years ago
  • Extinction training suppresses activity of fear memory ensembles across the hippocampus and alters transcriptomes of fear-encoding cells
    Published on 2024-06-14
    2 years ago
  • Genome-wide association studies of coffee intake in UK/US participants of European ancestry uncover cohort-specific genetic associations
    Published on 2024-06-11
    2 years ago
  • Cracking the chicken and egg problem of schizophrenia and substance use: Genetic interplay between schizophrenia, cannabis use disorder, and tobacco smoking
    Published on 2024-06-11
    2 years ago
« Previous 1 … 86 87 88 89 90 … 143 Next »
Journal of Psychopharmacology
  • A phase 1 study to assess potential interaction between ASP8062 and alcohol in healthy adult subjects
    Published on 2022-01-07
    5 years ago
  • Incident infection during the first year of treatment – A comparison of clozapine and paliperidone palmitate long-acting injection
    Published on 2022-01-07
    5 years ago
  • Lifetime use of MDMA/ecstasy and psilocybin is associated with reduced odds of major depressive episodes
    Published on 2022-01-05
    5 years ago
  • Validation of the Psychological Insight Scale: A new scale to assess psychological insight following a psychedelic experience
    Published on 2022-01-05
    5 years ago
  • MDMA/ecstasy use and psilocybin use are associated with lowered odds of psychological distress and suicidal thoughts in a sample of US adults
    Published on 2022-01-05
    5 years ago
  • The effects of psilocybin on cognitive and emotional functions in healthy participants: Results from a phase 1, randomised, placebo-controlled trial involving simultaneous psilocybin administration and preparation
    Published on 2022-01-04
    5 years ago
  • Impact of drug-induced Parkinsonism and tardive dyskinesia on health-related quality of life in schizophrenia
    Published on 2022-01-04
    5 years ago
« Previous 1 … 86 87 88 89 90 … 150 Next »
European Neuropsychopharmacology
  • Sodium nitroprusside enhances the antipsychotic-like effect of olanzapine but not clozapine in the conditioned avoidance response test in rats
    Published on 2022-05-27
    4 years ago
  • The U-shaped relationship between parental age and the risk of bipolar disorder in the offspring: A systematic review and meta-analysis
    Published on 2022-05-27
    4 years ago
  • New insights of the role of the KCNH2 gene in schizophrenia: An fMRI case-control study
    Published on 2022-05-27
    4 years ago
  • Screening the European pharmacovigilance database for reports of clozapine-related DRESS syndrome: 47 novel cases
    Published on 2022-05-26
    4 years ago
  • The time to act: early recommendations on patient care for psychiatric disorders in post-acute COVID-19 syndrome (PDPACS); Response to Llach and Ammella´s letter to the editor (Llach and Anmella 2022)
    Published on 2022-05-21
    4 years ago
  • Neural underpinnings of emotion regulation subgroups in remitted patients with recently diagnosed bipolar disorder
    Published on 2022-05-11
    4 years ago
  • Social Stress in Bipolar Disorder
    Published on 2022-05-11
    4 years ago
« Previous 1 … 86 87 88 89 90 … 168 Next »

   Pharma Pub